Moderna cited “an ongoing internal investigation into certain matters” in its announcement.

In some cases hospital staff kept no watch over outside-looking-in connections between manufacturers and scanners.

Computer scientists, rheumatologists and immunologists have pooled skill sets to develop a neural network that can distinguish between rheumatoid and psoriatic arthritis while also recognizing healthy joints with no arthritis at all.

Biohaven is known as the company behind Nurtec ODT, a dual-acting migraine therapy approved for both the acute treatment and episodic prevention of migraines.

The FDA has OK’d the use of MR imaging for patients implanted with an autonomic heart-stimulation device as long as the device’s labeled guidelines are followed at the imaging site.

The deal brings Integra’s more than 40,000 Medicaid members and network of care management teams to Anthem, which serves more than 118 million people.

As a result, the company stated it will pause the practice of prescribing controlled substances as a treatment for ADHD such as Adderall and Ritalin for new patients starting May 9.

Hello Heart, a digital therapeutics company that focuses on heart health, has raised $70 million in a Series D funding round.